Dermatofibrosarcoma protuberans: a partial response to imatinib therapy.
Mehrany
Khosrow
K
Department of Dermatology, Oregon Health and Science University, and Oregon Health and Cancer Institute, Portland, Oregon 97239, USA.
Swanson
Neil A
NA
Heinrich
Michael C
MC
Weenig
Roger H
RH
Lee
Ken K
KK
White
Clifton R
CR
Devere
Theresa S
TS
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D002610:Cheek; D018223:Dermatofibrosarcoma / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D005153:Facial Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D006801:Humans; D000068877:Imatinib Mesylate; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate